RE: Tiziana Life Sciences Granted FDA Fast Track Designation25 Jul 2024 11:28
Great news, shares only closed at $1. In the old days might have been $2. Just hope some momentum can be gained in the coming weeks.
I have said it before and say it again, for me the real strength and effect of Foralumab will be as a combination drug with other neuro disease specific drugs from other pharmas. I hope TLSA are working on this and something is announced soon, perhaps that will finally give the share price lift off. A $5 share price is not out of the question.